Cardiovascular Risk Increased With Metabolic Syndrome in Psoriasis
Metabolic syndrome (MetSyn) is prevalent among patients with psoriasis and is associated with increased cardiovascular risk.
Metabolic syndrome (MetSyn) is prevalent among patients with psoriasis and is associated with increased cardiovascular risk.
Investigators sought to determine whether a very low-calorie diet is feasible and acceptable to achieve and maintain a weight loss of 10% or more in patients with nonalcoholic fatty liver disease.
Metabolic surgery is associated with a reduced risk for major adverse cardiovascular events and death among patients with previous myocardial infarction.
The largest study examining the relationship between alopecia areata and cardiovascular disease in a US cohort is reviewed.
Metabolic syndrome (MetS) is associated with a lethal outcome for patients with COVID-19.
Hypertension, dyslipidemia, and obesity were among the conditions investigators reviewed as being affected by the underlying inflammation associated with rosacea.
The prevalence of metabolic syndrome is rising at an unequal rate among different patient demographics.
Skeletal muscle alterations in rheumatoid arthritis are often overlooked despite their important role in disability and cardiometabolic disease development.
The prevalence of metabolic syndrome among young adults in the United States is rising.
Amino acid dysmetabolism can be detected during the early postpartum period and is predictive of the transition from gestational diabetes to type 2 diabetes.